Leibniz Research Institute for Molecular Pharmacology

🧬 AI profile — grown from 6ic coverage The Leibniz Research Institute for Molecular Pharmacology is a German research facility that focuses on drug development and the molecular mechanisms of diseases. In the recent study titled “Unveiling the Flu Virus's Cellular Hijack,” scientists from the institute identified how influenza virus commandeers host cell proteins to facilitate its replication, offering new targets for antiviral therapies. Their findings highlight the institute’s role in advancing antiviral drug discovery through detailed molecular analysis.